Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands

Cancer Cell
Marco A ArapR Pasqualini

Abstract

We have recently identified glucose-regulated protein-78 (GRP78) as a relevant molecular target expressed in metastatic tumors by fingerprinting the circulating repertoire of antibodies from cancer patients. Here we design and evaluate a ligand-receptor system based on the tumor cell membrane expression of GRP78. We show that GRP78 binding peptide motifs target tumor cells specifically in vivo and in human cancer specimens ex vivo. Moreover, synthetic chimeric peptides composed of GRP78 binding motifs fused to a programmed cell death-inducing sequence can suppress tumor growth in xenograft and isogenic mouse models of prostate and breast cancer. Together, these preclinical data validate GRP78 on the tumor cell surface as a functional molecular target that may prove useful for translation into clinical applications.

References

Dec 1, 1990·The Journal of Cell Biology·S L Schmid, L L Carter
Feb 1, 1994·International Journal of Radiation Oncology, Biology, Physics·A C KoongA J Giaccia
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·C JamoraA S Lee
Aug 2, 1996·Journal of Medicinal Chemistry·M M JavadpourM L McLaughlin
Apr 7, 2000·The American Journal of Pathology·H HashizumeD M McDonald
Sep 5, 2001·Nature Cell Biology·L RavagnanG Kroemer
Feb 1, 2002·Nature Medicine·Wadih ArapRenata Pasqualini
Feb 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Wadih ArapErkki Ruoslahti
Oct 2, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Amin HajitouAgnès Noël
Dec 21, 2002·The Journal of Biological Chemistry·Bong Kyung ShinSamir M Hanash
May 27, 2003·Nature Reviews. Immunology·Christopher V Nicchitta
Oct 28, 2003·The American Journal of Pathology·Cheng LiuThomas Edgington
Mar 5, 2004·Cancer Cell·Serena MarchiòWadih Arap
May 11, 2004·Nature Medicine·Mikhail G KoloninWadih Arap

❮ Previous
Next ❯

Citations

Feb 24, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Xiao-Li DuMing-Rong Wang
Jul 29, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Britta Hardy, Annat Raiter
Jan 22, 2010·Apoptosis : an International Journal on Programmed Cell Death·U K Misra, S V Pizzo
May 26, 2011·Pharmaceutical Research·Bin QinKun Cheng
Sep 5, 2012·Cellular Oncology (Dordrecht)·Britta HardyYaron Niv
Aug 8, 2008·Expert Reviews in Molecular Medicine·Joshua C AndersonCandece L Gladson
Jul 19, 2011·Bioconjugate Chemistry·Daniel K BonnerPaula T Hammond
Mar 22, 2007·Molecular Pharmaceutics·Ying LiuKim D Janda
Jan 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Paul J MintzRenata Pasqualini
Nov 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yong FuAmy S Lee
Mar 2, 2010·Proceedings of the National Academy of Sciences of the United States of America·Marina Cardó-VilaRenata Pasqualini
Aug 23, 2008·The Journal of Biological Chemistry·Ricardo J GiordanoWadih Arap
Jun 3, 2009·Antioxidants & Redox Signaling·Richard C Austin
Apr 18, 2008·Molecular Biology of the Cell·Nathan MyhillThomas Simmen
Mar 9, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T WinderH-J Lenz
Aug 7, 2009·Journal of Biomechanical Engineering·Todd O PangburnEfrosini Kokkoli
Nov 11, 2011·Science Translational Medicine·Kirstin F BarnhartRenata Pasqualini
Sep 25, 2009·Journal of Virology·Tomoyuki HondaKeizo Tomonaga
Aug 19, 2008·Molecular Cancer Research : MCR·Jenilyn J VirreyAmy S Lee
Jan 21, 2012·Blood·Dwayne L Barber
Aug 2, 2005·Neuro-oncology·Michael W Graner, Darell D Bigner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis